1. Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials. (28th August 2020) Authors: Kluetz, Paul G; King-Kallimanis, Bellinda L; Suzman, Daniel; Chang, Elaine; Brave, Michael M; Weinstock, Chana; Bhatnagar, Vishal; Beaver, Julia A; Chuk, Meredith K Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 5(2021) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Demystifying the estimand framework: a case study using patient-reported outcomes in oncology. Issue 10 (October 2020) Authors: Fiero, Mallorie H; Pe, Madeline; Weinstock, Chana; King-Kallimanis, Bellinda L; Komo, Scott; Klepin, Heidi D; Gray, Stacy W; Bottomley, Andrew; Kluetz, Paul G; Sridhara, Rajeshwari Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: e488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Exploration of baseline patient-reported side effect bother from cancer therapy. (June 2020) Authors: Roydhouse, Jessica K; King-Kallimanis, Bellinda L; Roy, Pourab; Weinstock, Chana; Krol, Danielle; Daniels, Selena R; Suzman, Daniel L; Beaver, Julia A; Kluetz, Paul G Journal: Clinical trials Issue: Volume 17:Number 3(2020) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer. (17th November 2020) Authors: Anscher, Mitchell S.; Chang, Elaine; Gao, Xin; Gong, Yutao; Weinstock, Chana; Bloomquist, Erik; Adeniyi, Oluseyi; Charlab, Rosane; Zimmerman, Sarah; Serlemitsos‐Day, Maritsa; Ning, Yang Min; Mayrosh, Ruth; Fuller, Barbara; Trentacosti, Ann Marie; Gallagher, Pamela; Bijwaard, Karen; Philip, Reena;... Journal: Oncologist Issue: Volume 26:Number 2(2021) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials. Issue 9 (September 2021) Authors: Fallah, Jaleh; Zhang, Lijun; Amatya, Anup; Gong, Yutao; King-Kallimanis, Bellinda; Bhatnagar, Vishal; Weinstock, Chana; Suzman, Daniel L; Agrawal, Sundeep; Chang, Elaine; Anscher, Mitchell S; Chi, Dow-Chung; Xu, James X; Brewer, Jamie R; Brave, Michael H; Hadadi, Mehrnoosh; Theoret, Marc R; Kluet... Journal: Lancet oncology Issue: Volume 22:Issue 9(2021) Page Start: 1230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Using a Benefit–Risk Analysis Approach to Capture Regulatory Decision Making: Renal Cell Carcinoma. Issue 3 (27th September 2019) Authors: Raju, G. K.; Gurumurthi, Karthik; Domike, Reuben; Singh, Harpreet; Weinstock, Chana; Kluetz, Paul; Pazdur, Richard; Woodcock, Janet Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 3(2020) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗